{
"id":"mk19_b_cv_t29",
"number":29,
"bookId":"cv",
"title":{
"__html":"Major Risk Factors for Sudden Cardiac Death in Patients With HCM<sup>a</sup>"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"97c32d",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 29. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_cv_t29"
}
]
},
"Major Risk Factors for Sudden Cardiac Death in Patients With HCM",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2b737b",
"class":"cell txt l",
"children":[
"Sudden death in a first-degree relative or close relative age ≤50 y"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ed99aa",
"class":"cell txt l",
"children":[
"LV wall thickness ≥30 mm"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c7eadb",
"class":"cell txt l",
"children":[
"≥1 Episode of syncope thought to be arrhythmic in nature"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e773da",
"class":"cell txt l",
"children":[
"LV apical aneurysm"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"08cb31",
"class":"cell txt l",
"children":[
"LVEF <50%"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"HCM = hypertrophic cardiomyopathy; LV = left ventricular; LVEF = left ventricular ejection fraction."
],
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"For adults with one or more major risk factors, it is reasonable to offer an implantable cardioverter-defibrillator (class 2a recommendation)."
],
[
"Information from Ommen SR, Mital S, Burke MA, et al; Writing Committee Members. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142:e558-e631. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/33215931",
"target":"_blank"
},
"children":[
"PMID: 33215931"
]
},
" doi:10.1161/CIR.0000000000000937"
]
]
}